Paul Marks, Past President of MSKCC, Dies
Paul Marks, Past President of MSKCC, Dies
A cancer researcher with a talent for leadership, Marks turned the Memorial Sloan Kettering Cancer Center into one of the world’s foremost oncology research institutions.
Paul Marks, Past President of MSKCC, Dies
Paul Marks, Past President of MSKCC, Dies

A cancer researcher with a talent for leadership, Marks turned the Memorial Sloan Kettering Cancer Center into one of the world’s foremost oncology research institutions.

A cancer researcher with a talent for leadership, Marks turned the Memorial Sloan Kettering Cancer Center into one of the world’s foremost oncology research institutions.

leukemia
Cracking Down on Cancer: A Profile of Owen Witte
Cracking Down on Cancer: A Profile of Owen Witte
Diana Kwon | Apr 1, 2020
Through his studies on cancer-causing viruses, the University of California, Los Angeles, professor has helped develop lifesaving treatments.
Leukemia Relapses May Arise From Specialized Cells
Leukemia Relapses May Arise From Specialized Cells
Sukanya Charuchandra | Nov 30, 2018
Targeting the transient group of cells could prevent recurrence of the disease.
Genome, Exome, RNA Sequencing Applied to Pediatric Cancer Cases
Genome, Exome, RNA Sequencing Applied to Pediatric Cancer Cases
Ashley Yeager | Oct 18, 2018
Combining data from the genetic testing techniques can guide patient care, scientists say.
EPA Stalls Release of Carcinogen Report
EPA Stalls Release of Carcinogen Report
Sukanya Charuchandra | Jul 9, 2018
An investigation by Politico finds the agency has been sitting on an assessment of formaldehyde’s cancer risks for a year and a half.
Prevalent Form of Childhood Leukemia May Be Preventable
Prevalent Form of Childhood Leukemia May Be Preventable
Sukanya Charuchandra | May 22, 2018
Early exposure to common microbes could stop leukemia from manifesting in children.
Genetic Screens Provide Clues About Prognosis, Risk of Second Cancer
Genetic Screens Provide Clues About Prognosis, Risk of Second Cancer
Shawna Williams | Mar 31, 2018
Mutations in the TP53 gene appear to influence the prognosis and likelihood of future cancers in pediatric leukemia patients.
Researchers Publish First Pan-Cancer Genomic Analyses in Pediatric Patients
Researchers Publish First Pan-Cancer Genomic Analyses in Pediatric Patients
Catherine Offord | Feb 28, 2018
Two large-scale studies reveal new insights into the genomic characteristics of childhood cancers.
New CAR T-Cell Therapy Shows Promise in Trial for Leukemia
New CAR T-Cell Therapy Shows Promise in Trial for Leukemia
Katarina Zimmer | Nov 21, 2017
The immunotherapy, which targets CD22 on cancer cells rather than CD19, might prove useful in patients for whom previous T-cell treatments were unsuccessful. 
First CAR T-Cell Therapy Approved in U.S.
First CAR T-Cell Therapy Approved in U.S.
Shawna Williams | Aug 30, 2017
The genetically modified blood cells will be used for patients with a type of acute lymphoblastic leukemia, when other treatments fail.